Home >> Healthcare >> Food & Beverage >>

Global Histone Deacetylase 2 Market Data Survey Report 2013-2025

Published: Mar-2019 | Format: PDF | HeyReport | Number of pages: 72 | Code: MRS - 414523

Summary
The global Histone Deacetylase 2 market will reach xxx Million USD in 2019 with CAGR xx% 2019-2025. The main contents of the report including:
Global market size and forecast
Regional market size, production data and export & import
Key manufacturers profile, products & services, sales data of business
Global market size by Major Application
Global market size by Major Type
Key manufacturers are included based on company profile, sales data and product specifications etc.:
    4SC AG 
    Acetylon Pharmaceuticals, Inc. 
    Chipscreen Biosciences Ltd 
    Curis, Inc. 
    GlaxoSmithKline Plc 
    HitGen LTD 
    Italfarmaco S.p.A. 
    MEI Pharma, Inc. 
    Merck & Co., Inc. 
    Rodin Therapeutics 
    Sigma-Tau S.p.A. 
    TetraLogic Pharmaceuticals 
    Yungjin Pharm. Co., Ltd
Major applications as follows:
    Colon Cancer 
    Non-Hodgkin Lymphoma 
    Alopecia 
    Bladder Cancer 
    Others
Major Type as follows:
    RCY-1305 
    HG-3001 
    CS-3158 
    ACY-957 
    Others
Regional market size, production data and export & import:
    Asia-Pacific
    North America
    Europe
    South America
    Middle East & Africa
Table of Contents
1 Global Market Overview
    1.1 Scope of Statistics
        1.1.1 Scope of Products
        1.1.2 Scope of Manufacturers
        1.1.3 Scope of Application
        1.1.4 Scope of Type
        1.1.5 Scope of Regions/Countries
    1.2 Global Market Size
2 Regional Market
    2.1 Regional Production
    2.2 Regional Demand
    2.3 Regional Trade
3 Key Manufacturers
    3.1 4SC AG 
        3.1.1 Company Information
        3.1.2 Product & Services
        3.1.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.1.4 Recent Development
    3.2 Acetylon Pharmaceuticals, Inc. 
        3.2.1 Company Information
        3.2.2 Product & Services
        3.2.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.2.4 Recent Development
    3.3 Chipscreen Biosciences Ltd 
        3.3.1 Company Information
        3.3.2 Product & Services
        3.3.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.3.4 Recent Development
    3.4 Curis, Inc. 
        3.4.1 Company Information
        3.4.2 Product & Services
        3.4.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.4.4 Recent Development
    3.5 GlaxoSmithKline Plc 
        3.5.1 Company Information
        3.5.2 Product & Services
        3.5.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.5.4 Recent Development
    3.6 HitGen LTD 
        3.6.1 Company Information
        3.6.2 Product & Services
        3.6.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.6.4 Recent Development
    3.7 Italfarmaco S.p.A. 
        3.7.1 Company Information
        3.7.2 Product & Services
        3.7.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.7.4 Recent Development
    3.8 MEI Pharma, Inc. 
        3.8.1 Company Information
        3.8.2 Product & Services
        3.8.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.8.4 Recent Development
    3.9 Merck & Co., Inc. 
        3.9.1 Company Information
        3.9.2 Product & Services
        3.9.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.9.4 Recent Development
    3.10 Rodin Therapeutics 
        3.10.1 Company Information
        3.10.2 Product & Services
        3.10.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.10.4 Recent Development
    3.11 Sigma-Tau S.p.A. 
        3.11.1 Company Information
        3.11.2 Product & Services
        3.11.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
        3.11.4 Recent Development
    3.12 TetraLogic Pharmaceuticals 
        3.12.1 Company Information
        3.12.2 Product & Services
        3.12.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
    3.13 Yungjin Pharm. Co., Ltd
        3.13.1 Company Information
        3.13.2 Product & Services
        3.13.3 Business Data (Capacity, Sales Revenue, Volume, Price, Cost and Margin)
4 Major Application
    4.1 Colon Cancer 
        4.1.1 Overview
        4.1.2 Colon Cancer  Market Size and Forecast
    4.2 Non-Hodgkin Lymphoma 
        4.2.1 Overview
        4.2.2 Non-Hodgkin Lymphoma  Market Size and Forecast
    4.3 Alopecia 
        4.3.1 Overview
        4.3.2 Alopecia  Market Size and Forecast
    4.4 Bladder Cancer 
        4.4.1 Overview
        4.4.2 Bladder Cancer  Market Size and Forecast
    4.5 Others
        4.5.1 Overview
        4.5.2 Others Market Size and Forecast
5 Market by Type
    5.By RCY-1305 
    5.1 RCY-1305 
        5.1.1 Overview
        5.1.2 RCY-1305  Market Size and Forecast
    5.2 HG-3001 
        5.2.1 Overview
        5.2.2 HG-3001  Market Size and Forecast
    5.3 CS-3158 
        5.3.1 Overview
        5.3.2 CS-3158  Market Size and Forecast
    5.4 ACY-957 
        5.4.1 Overview
        5.4.2 ACY-957  Market Size and Forecast
    5.5 Others
        5.5.1 Overview
        5.5.2 Others Market Size and Forecast
6 Price Overview
    6.1 Price by Manufacturers
    6.2 Price by Application
    6.3 Price by Type
7 Conclusion

                        
            

Inquiry For Buying

Please fill your details below, to inquire about this report:
Indicates required fields

Request Sample

Please fill your details below, to receive sample report:
Indicates required fields

  • Payment Mode
Single User | $(USD)1500 View Pricing